PharmTech News

Articles

Shire plans to establish a 550,000-square-foot campus that will focus on innovation in rare diseases and highly specialized conditions.

Shire to Create Rare Disease Innovation Hub in Cambridge, Massachusetts

ESCMID has organized various activities to promote prudent use of antibiotics in Europe.

ESCMID Promotes Prudent Use of Antibiotics to Fight Resistance

The company plans to expand access to its Prevanar 13 vaccine in humanitarian emergency settings.

Pfizer Expands Humanitarian Assistance Program

Avecia is adding drug substance capacity at its Milford, MA manufacturing site.

Nitto Avecia Expands Oligonucleotide Manufacturing Capacity

Roche launched imCORE, a global network of cancer immunotherapy centers of excellence.

Roche Launches Immunotherapy Research Network

NIH researchers developed a test to identify existing drugs that might be able to combat drug-resistant bacteria.

Existing Drugs May Be Repurposed to Fight Drug-Resistant Bacteria

The agreement allows Bristol-Myers Squibb exclusive license to manufacture and commercialize Nitto Denko Corporation’s NASH treatment.

BMS Enters into License Agreement for NASH Drug

British artificial intelligence company BenevolentAI has signed an exclusive license for a series of novel clinical-stage drug candidates with Johnson & Johnson.

British Artificial Intelligence Firm Seals Drug-Development Deal with Janssen

The study in 48 healthy adults will assess the safety and immunogenicity of a prime-boost regime of two different intranasal doses of the RSV vaccine, SynGem.

Mucosis Starts Phase I Trial of Needle-Free Nasal-Spray RSV Vaccine

Researchers in the University of Dundee have discovered a new method of activating drugs to combat visceral leishmaniasis. The discovery could lead to better treatments for neglected tropical diseases.

Bio/Pharma News